# A Clinical Study to Evaluate the Safety and Efficacy of GT802 Injection in the Treatment of Relapsing/Refractory Multiple Sclerosis

> **NCT07748637** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **Daishi Tian** · enrollment: 12 (estimated)

## Conditions studied

- Multiple Sclerosis (MS)

## Interventions

- **BIOLOGICAL:** GT802 Injection

## Key facts

- **NCT ID:** NCT07748637
- **Lead sponsor:** Daishi Tian
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-10-28
- **Primary completion:** 2031-07-30
- **Final completion:** 2031-07-30
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2026-09-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07748637

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07748637, "A Clinical Study to Evaluate the Safety and Efficacy of GT802 Injection in the Treatment of Relapsing/Refractory Multiple Sclerosis". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07748637. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*